Summary of INOVIO BIOMEDICAL CORP

Item 9.01 Financial Statements and Exhibits.

(a) Financial Statements of Businesses Acquired.

The financial information required by this item with respect to the Merger was previously filed on a first amendment to the Initial 8-K filed on June 16, 2009.

(b) Pro Forma Financial Information.

Pursuant to paragraph (a)(4) of Item 9.01 of Form 8-K, the attached pro forma financial information was omitted from disclosure contained in the Initial 8-K. Attached hereto as Exhibit 99.1 and Exhibit 99.2, respectively, and incorporated herein by reference is the required pro forma financial information.

(d) Exhibits.

99.1*    Unaudited Pro Forma Combined Financial Statements
         Unaudited Pro Forma Combined Balance Sheets as of December 31, 2008
         Unaudited Pro Forma Combined Statements of Operations for the year ended
          December 31, 2008
         Notes to Unaudited Pro Forma Combined Financial Statements




99.2    Unaudited Pro Forma Combined Condensed Financial Information
        Unaudited Pro Forma Combined Condensed Balance Sheet as of March 31, 2009
        Unaudited Pro Forma Combined Condensed Statement of Operations for the
        three months ended March 31, 2009
        Notes to Unaudited Pro Forma Combined Condensed Financial Information

* Incorporated by reference to the Unaudited Pro Forma Combined Financial Statements included in the Joint Proxy Statement/Prospectus filed by Inovio with the Securities and Exchange Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, on May 1, 2009, relating to Inovio's Registration Statement on Form S-4, as amended
(Registration No. 333-156035)